Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pharmacodynamics Study”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT04077671
What this trial is testing

CHF6467 SAD and MAD in Patients With Diabetic Foot Ulcer

Who this might be right for
Diabetic Neuropathic Foot Ulcers
Chiesi Farmaceutici S.p.A. 93
Testing effectiveness (Phase 2)Ended earlyNCT01624636
What this trial is testing

Safety and Tolerability of Intravenous LFG316 in Wet Age-related Macular Degeneration (AMD).

Who this might be right for
Neovascular Age-related Macular Degeneration
Novartis Pharmaceuticals 1
Early research (Phase 1)Study completedNCT04015232
What this trial is testing

Comparative Immunogenicity Study of Multiple Doses of Proposed Pegfilgrastim Biosimilar, INTP5 of Intas Pharmaceuticals Ltd., India Against Neulasta of Amgen Inc., USA in Healthy, Adult Human Subjects.

Who this might be right for
ImmunogenicityHealthy Volunteers
Intas Pharmaceuticals, Ltd. 200
Early research (Phase 1)UnknownNCT05989724
What this trial is testing

A First-in-Human Study of SON-DP in Participants With Relapsed/Refractory Intolerant to Standard of Care Therapies for Advanced/Metastatic Solid Tumors

Who this might be right for
Solid TumorBreast CancerPancreatic Cancer+2 more
Qurgen Inc. 150
Testing effectiveness (Phase 2)Study completedNCT00404768
What this trial is testing

The Safety, Tolerability And Metabolism Of GSK221149A, In Pregnant Women (30-36 Weeks), In Pre-Term Labor

Who this might be right for
Obstetric Labour, Premature
GlaxoSmithKline 93
Testing effectiveness (Phase 2)Study completedNCT01999582
What this trial is testing

Intravenous or Subcutaneous Dosing of Sotatercept (ACE-011) in Patients With End-Stage Kidney Disease on Hemodialysis

Who this might be right for
AnemiaKidney Failure, Chronic
Celgene 50
Early research (Phase 1)Study completedNCT06056024
What this trial is testing

Test How Well Different Doses of BI 3706674 Are Tolerated by People With Advanced Cancer in the Stomach and Oesophagus

Who this might be right for
Solid Tumor, KRAS Mutation
Boehringer Ingelheim 47
Testing effectiveness (Phase 2)Looking for participantsNCT05487170
What this trial is testing

RNK05047 in Subjects With Advanced Solid Tumors/Diffuse Large B-cell Lymphoma (CHAMP-1)

Who this might be right for
Advanced Solid TumorDLBCL
Ranok Therapeutics (Hangzhou) Co., Ltd. 32
Testing effectiveness (Phase 2)Study completedNCT01531777
What this trial is testing

Dose Finding and Pharmacokinetics/Pharmacodynamics Study of Apatinib in the Treatment of Advanced Colorectal Cancer

Who this might be right for
Colorectal Cancer
Jiangsu HengRui Medicine Co., Ltd. 40
Early research (Phase 1)Study completedNCT05576298
What this trial is testing

A Clinical Study Comparing the Pharmacokinetics and Pharmacodynamic Characteristics of Insulin Degludec Injection (RD15003) and Insulin Degludec Injection (Tresiba®) in Healthy Subjects

Who this might be right for
Type 2 Diabetes
Sunshine Lake Pharma Co., Ltd. 46
Testing effectiveness (Phase 2)Study completedNCT05421429
What this trial is testing

KN057 Multiple Dose Study in Moderately Severe to Severe Hemophilia

Who this might be right for
Hemophilia
Suzhou Alphamab Co., Ltd. 24
Early research (Phase 1)Not Yet RecruitingNCT07001839
What this trial is testing

A Phase Ib Study of QLS4131 in Subjects With Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus Erythematosus
Qilu Pharmaceutical Co., Ltd. 108
Not applicableStudy completedNCT00508677
What this trial is testing

Mazindol in Children With ADHD : Open-label, Efficacy, Safety and Pharmacokinetic Pilot Trial

Who this might be right for
Attention Deficit Hyperactivity Disorder
Assistance Publique - Hôpitaux de Paris 24
Not applicableStudy completedNCT00281619
What this trial is testing

PK-PD Study of Mycophenolic Acid (CellCept) in Pediatric Kidney Transplant Patients

Who this might be right for
Kidney Transplant
Children's Hospital Medical Center, Cincinnati 29
Early research (Phase 1)Temporarily pausedNCT06739707
What this trial is testing

Subcutaneously Administered MD-18 for the Treatment of Obesity and Diabetes

Who this might be right for
Healthy Volunteer
Cohen Global, Ltd. 54
Early research (Phase 1)Looking for participantsNCT07133828
What this trial is testing

Learn About the Safety of BIIB142 and How it is Processed in the Body of Healthy Adult Participants Aged 18 to 55 Years Old

Who this might be right for
Healthy Volunteer
Biogen 78
Early research (Phase 1)Study completedNCT00796471
What this trial is testing

A Pharmacokinetics and Pharmacodynamics Study Under Fasting and Fed Conditions With Paliperidone Extended-release and Immediate-release Formulations

Who this might be right for
Schizophrenia
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 35
Early research (Phase 1)Ended earlyNCT03381144
What this trial is testing

The Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Effects of Single and Multiple Ascending Doses of GDC-0334 and the Effect of Food on the Pharmacokinetics of GDC-0334 in Healthy Adult Participants

Who this might be right for
Healthy Volunteers
Genentech, Inc. 66
Testing effectiveness (Phase 2)WithdrawnNCT02584777
What this trial is testing

A Phase II Non-Controlled, Open-Label, Efficacy, Safety, Pharmacokinetic, and Pharmacodynamic Study of Pacritinib in Myelofibrosis

Who this might be right for
Primary Myelofibrosis
Baxalta now part of Shire
Early research (Phase 1)Study completedNCT02217839
What this trial is testing

Multiple Ascending Dose Tolerability, Pharmacokinetic and Pharmacodynamic Study of DG3173

Who this might be right for
Healthy
Aspireo Pharmaceuticals Limited 42
Next Page